Stay Up to Date

By signing up below to receive more information, you will receive email updates about VEOZA and related materials, and you may be contacted by an Astellas representative.

Please note that, by requesting further information, you are not obliged to accept a visit from an Astellas representative.

Please note that fields marked with (*) are required.
Terms and Conditions

I have read and agree to the Terms of Use and Privacy Notice.*

Adverse events should be reported. For Ireland, Healthcare professionals are asked to report any suspected adverse reactions via; HPRA Pharmacovigilance, Website: www.hpra.ie or Astellas Pharma Co. Ltd. Tel: +353 1 467 1555, Email: irishdrugsafety@astellas.com


MAT-IE-VEO-2024-00044 August 2024

Thank you

Your request has been submitted. 


MAT-IE-VEO-2024-00044 August 2024